Mudar Dalloul

ORCID: 0000-0003-3538-086X · 10 papers in corpus
article 2017
General pain, pelvic regional pain, gastrointestional and affective symptoms are common among women with endometriosis-related pain and may affect study retention during clinical trials
·doi:10.1016/j.fertnstert.2017.07.143
article 2015
Effect of lupron vs norethindrone treatment on lipid profile of women with symptomatic endometriosis
·doi:10.1016/j.fertnstert.2015.07.499
article 2015
Improvement in endometriosis-related pelvic pain with leuprolide or norethindrone treatment
·doi:10.1016/j.fertnstert.2015.07.507
article 2014
Health-related quality of life improvement in women with endometriosis-associated pain during treatment
·doi:10.1016/j.fertnstert.2014.07.055
article 2013
Changes in bone density in women with endometriosis on leuprolide vs norethindrone treatment
·doi:10.1016/j.fertnstert.2013.07.1700
article 2012
Changes in self-reported symptoms of women with endometriosis during treatment
·doi:10.1016/j.fertnstert.2012.07.777
book-chapter 2011
Urinary Cortisol Metablism in Women with Endometriosis
·doi:10.1210/endo-meetings.2011.part3.p26.p3-200
article 2010
Changes in quality of life (QOL) in women with symptomatic endometriosis by pain type during treatment
·doi:10.1016/j.fertnstert.2010.07.797
article 2010
Prevalence of metabolic syndrome and changes in lipid profile of women with endometriosis during treatment
·doi:10.1016/j.fertnstert.2010.07.799
article 2008
Serum F11R/JAM-a levels in women with symptomatic endometriosis
·doi:10.1016/j.fertnstert.2008.07.247